Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-07-05 to 2024-07-26
Current total value of award: $128442.7
Description: 4565107229!OCREVUS 300 MG/10 ML VIAL 10ML